OD's In America EBS has THE main stream Narcan that dominates the market. With increasing over doses though out America. Earnings could make this move like crazyyyyyyyy. If it is not this earnings then it is next, this stock can pop 50-100% in one day. Its a scalp trade. Longby LeapTradesUpdated 5
EBS: going to 16-20WHO just approved ACCAM2000 for mpox ! Although I bought it because of Narcan, this is GOOOD news. Waiting on EEE.Virus news. If this works also out we will be heading above 100Longby darth.stocks13136
Emergent Bio: Clear LONGDidn't change much yesterday's data... It remains the only solution out of the lethality rates of current opioid crisis !!! Target above 30 . For most of us this is a once in a lifetime OpprtunityLongby darth.stocks5
EBS Base Breakout SetupHey everybody got my camera working for this trade idea. Here we have the ebs stock setting up for a breakout in an uptrend and we're hoping for a bullish continuation here. I describe my entry points my stop loss and my profit target one and the logic behind them and how to position your share count so you can manage your risk and prepare to lose as much or as little money that you want if the trade goes against you every decision in this trade has meaning and logic to it that pertains to the particular stock and the setup therefore you know why you are doing everything that you're doing when trading. Let me know if you have any questions or if this is new to you or if you need help setting it up or calculating how much money you should win or lose. The only issue with this stock is that it's not in the technology sector and it's not in the communication sector so it is not in the most high performing sector right now although the healthcare sector is performing pretty decently with financials as well.Editors' picksEducation03:48by PappyTradingUpdated 44113
EBS - June 24 Qullamaggie Breakout and Episodic PivotThis is part of a Qullamaggie Breakout and Episodic Pivot study I am currently conducting Qulla Breakout & EP (Discretionary & Systematic) 🚀 Swing Trend Strategy focused on Breakouts based on repeated momentum and Episodic Pivots based on unexpected news/fundamentals that is not properly priced in. The entery requirements are always price consolidation and tighteningLongby Ronin_traderUpdated 0
Short EBSA short at 3.03 to 2.54 with the necessary risk management will bring a 16.08% returnShortby KyleUK0
EBS- Quasimodo patternEBS- Quasimodo pattern -Key level support. -Demand zone. -Less supply volume.by phanvinhhai115
EBS a biotech company focused on vaccinesEBS is a small biotechnology company whose forte is the clean processing and manufacturing facility that the FDA requires for certain bioprocessing to be certified for delivery of products to end-user patients. It is not a research facility like the one in China that accidentally released COVID and the global impact will be likely felt for another decade. EBS does depend on federal support and income from contract work from vaccine manufacturers. There is reasonable expectation or persistent and consistent revenues ongoing without fail unless the FDA decertified the facilities. On the chart, EBS is in a flat bottom triangle on its base. It is presently rising out of the triangle and towards the mean anchored VWAP It is just above The POC line which functions as dynamic support in the demand zone. I see a long trade with the stop loss below the POC line, the first target the blue line representing one standard deviation above the mean VWAP at about 9.4 while the second target is the redline two standard deviations above the mean VWAP at about 10.05 while the final target contemplates that EBS will challenge the high in May of 10.75. by AwesomeAvaniUpdated 3
$EBS - Narcan over the counter nose spray & Earnings 2/27I usually stray away from bio/biotech b/c of how volatile it is, but $EBS seems to be established with a $800M+ market cap, strong historicals, 20 PE ratio, and seems to be getting close to bottom. They also have an exciting narcan nasal spray product that can be sold over the counter they are working on releasing in 2023. Very relevant with all the overdoses going on in the US. What do you guys think? by ObiWanJacoby93113
$EBS levelsAdded some levels for EBS after 20% up side EBS got news on approval on nasal productby JoaoKunha0
EBS long 12.00-9.00$The price is approaching the strong level of $10.60, and there is already increased interest in this stock. This stock has been showing growth in December for many years, so it makes sense to consider buying in the $12.00-9.00 area, stop-loss at $8.5. The first target is $25, the second target is $35.Longby CDZV_trader2
Is EBS a buy as it hits a critical support level? EBS is currently hitting a critical support level around the 25 levels, which has been tested multiple times as key support and resistance level since 2009. I am planning on buying at this current level, with a very high-profit target and a tight 5% stop loss below the support level. The ATH is over 400% above the current price, so there's a lot of upside potential in this trade, but it will need to be managed carefully since the market is in a downtrend right now. Longby spiritualhealer117Updated 0
EBS: It's pretty bad when you underperform TNXPConsidering TNXP does... well... nothing, EBS underperforming TNXP is disappointing. Still holding and will continue to buy shares if SP falls back into the gray area at $25-$32. Monthly hammer + continuation off a high volume node + 2.618 fib should indicate a trend reversal. EBS was never a "squeeze" play because it's already worth a billion dollars. Additionally, I don't believe monkey pox is a serious pandemic regardless of what WHO says. EBS still has a pipeline of drugs that generates revenue and profit. With or without Monkey Pox, EBS should see $50-$60 (fibs) imo.Longby CrashWhenUpdated 0
EBS: FEAR THE MONKEYPOX!Apparently, there will be a WHO meeting next meeting concerning how serious Monkey Pox is going to be. Potential Long Term Head and Shoulders forming. $25 is a long term support level and Monthly VPOC. Speculative trade back to the 200W MA at $60Longby CrashWhenUpdated 774
EBS - Monkey pox is here Monkeypox has begun to expand. Vaccination is likely to increase in the coming months and this could lead to higher levels of shares of companies that produce vaccines.by StockBlog0
EBS - Head and Shoulders Pattern, Weekly1/1 line is a major Trend line Using the Fib circles the H&S pattern becomes more evident with the LS being rejected at the 1 level The H being formed at 1.618 and the RS being formed in the aftermath of the H formation I expect more downsides on this weekly timeframe until the strong support level is reached, which coincides also with the 1/2 Gann level by Bixley0
EBS ScalpJust broke trend, but long-term support below. I expect it to bounce and backtest the old trend, but no clue after. Could fall to $40 fib then maybe lower. I love this as a long at some point though. Company got bad press and missed a COVID vaccine delivery after a factory was shut down. It's open now though and they still have a huge backlog of business and 4 years of revenue growth.Longby competitiveDia367870
EBS LONGEBS broke the bear trend. Always when I saw such interception of MA lines, there was a huge growth. Now white candle (D) fixed above MA 50 and EMA 14, resistance broke. All point to growth. Longby MBAStocks1
EBS possible setup with 2 major supports EBS looks like a solid buy, I am investing at current price, if it goes down then I will add around second support. Reasons to buy: RSI looks oversold Stock trading at long term trendline 2021 consensus earning estimate 9.01 which means 7~ PE. Volume is increasing which shows it is getting attention Once the FDA will approve its facility, it will fly. Also, even if it breaks current level 2nd huge support level is not that far. So, doesn't have much to loose. Longby a4ankurbhutaniUpdated 2
$EBS Chart - Support, Resistance and TrendlineThree support and Three resistance drawn on daily chart. Trend reversal on daily chart. Need to look the chart again after one week Shortby catgovind0
EBSClassic Bullish divergence on both the 4hr and daily timeframe. Price has formed a descending wedge pattern and looks to have broken out. Support has been found at the 0.886 fibonacci retracement level which is also a historical daily resistance level before running to ATH.by Johnno-CenturionTradingUpdated 0
Pull Back Fishing Falling WedgeBullish engulfing candle today. The .886 fib level may have been the landing pad, but the bottom is not always the bottom. Biotech has been up and down so I am approaching this sector with caution for now. I have noted some biotech making daily or every other day yearly low and EBS made a new low yesterday and today although the 2 lows almost matched 58.79 today and 58.83 yesterday. Negative volume is high. Short interest is 7.2% Possible bullish divergence on RSI. No recommendationby lauralea4
Pull Back FishingAnother biotech. Does look like something gotta give soon. This stock is not afraid to gap down, so not for the faint of heart (o: EBS can gap up as well as it can gap down. Frequent gapping can indicate volatility. Not a recommendation. EBS pulled back on the 2nd leg a bit past the 0.618 fib level. If this were a Gartley pattern the landing pad would be the .786. While teaching yoga for many years, I have learned you have to be flexible (o: This one pulled back a bit below the 0.618, and possibly bottomed a bit above the 0.786. I am not sure the bottom is in yet though...maybe. Remains to be seen. Bullish falling wedge noted. Earnings 5-20 AMCby lauralea1